Products: BizInt Smart Charts Drug Development Suite

Release Information

The BizInt Smart Charts Drug Development Suite allows you to build reports from drug pipeline databases, clinical trials databases (including public registries like clinicaltrials.gov), and biomedical literature.

Subscribe to new releases by email or by RSS feed RSS Feed

Current Release

Current version: BizInt Smart Charts Drug Development Suite Version 5.4 (2021-11-26)

Download customer software (requires userid and password)

Download tryout software (fully functional trial)

System Requirements

Each release of BizInt Smart Charts has a fixed lifetime. Learn more.

Release History for the Last 18 Months

Introducing Version 5.4 (2021-11-26)

We are pleased to announce version 5.4 of the BizInt Smart Charts Drug Development Suite, introducing a simplified Reference Rows workflow and the ability to hide Reference Rows, as well as a few other improvements.

Reference Rows

  • New workflow: Send to Reference Rows command now sends a chart from BizInt Smart Charts directly to Reference Rows, without having to save the chart or go through a wizard.
  • Hide Reference Rows: a new Hide Reference Rows command is available on the right-mouse menu. You can also hide and move Reference Rows, and make them visible again, with the new View | Reference Rows panel.
  • Common Drug Name and Common Trial ID columns are now automatically generated when you combine charts, or when you send a combined chart to Reference Rows.
  • A new row number scheme, icons, and glyphs.
  • Learn more on the Reference Rows Tips page.

Databases and Hosts

  • Fixed a problem with Common Trial ID when the chart contained rows from EUDRACT.
  • PubMed: Captures the Corporate Source / Affiliation in the text export.
  • AdisInsight: Updated the database name for all of the AdisInsight databases. Extract NCT numbers to a column in AdisInsight Trials.

And Finally...

  • Color-Coding Cells: You can now choose to color-code cells in eight colors. Learn more on the Color-Coding Cells Tips page.
  • The Choose Color panel would occasionally get lost. This has been fixed.
  • Updated Mini Guide for BizInt Smart Charts Drug Development Suite 5.4.

New in Version 5.3.1 (2021-05-03)

  • Color-Coding Cells: You have always been able to color-code a cell background in yellow. With this release you can now choose to color-code cells in eight colors. This is particularly useful in user-added columns when you are regularly updating a chart. Learn more on our support page.

Announcing Version 5.3 (2021-03-28)

We are pleased to announce version 5.3 of the BizInt Smart Charts Drug Development Suite, with support for drug pipeline and clinical trial data from GlobalData.

Drug Pipelines

  • Support for GlobalData, using the "BizInt Smart Charts" export for drug search results. We welcome your feedback and you can expect to see several updates in the coming weeks.
  • Support for the new Target field in Adis Insight drug reports.
  • New BizInt Editor's Choice - Multi-Database template for multi-database pipeline reports provides a starting point for combined charts, with the most frequently used common columns.
    Use View | Apply Template... to apply this template to combined charts. You can edit the chart, and save it as a new template using File | Save as Template.
  • Improved column/field mapping for combined drug pipeline charts, starting with companies, mechanism of action, and targets. We will be continuing to improve the process for creating multi-database pipeline reports in upcoming releases.
  • Support for building pipeline charts from patent searches on both Cortellis and Cortellis Drug Discovery Intelligence. Please note that one patent might apply to more than one drug, so using Common Drug Name is not advised.

Clinical Trials

  • Support for GlobalData, using the "BizInt Smart Charts" export for clinical trial search results. We are continuing to work on column definitions and mapping, and welcome your feedback You can expect to see several updates in the coming weeks.
  • New BizInt Editor's Choice - Multi-Database template for multi-database clinical trial reports provides a starting point for combined charts, with the most frequently used common columns.
    Use View | Apply Template... to apply this template to combined charts. You can edit the chart, and save it as a new template using File | Save as Template.

Other Improvements

  • Changed "Columns..." on the View menu to read "Choose Columns..."
  • Added the Ctrl-Z keyboard shortcut for Undo
  • All charts saved with BizInt Smart Charts Drug Development Suite are now saved as .CHT files.

New and Fixed in Version 5.2.2 (2021-01-28)

  • PubMed: Adds preliminary support for PubMed text exports, since the PubMed XML export is no longer available. Exports from both PubMed and PubMedCentral are supported (learn more).
  • Cortellis Drug Discover Intelligence (new Integrity): this release extracts the Chemical Name / Description for drug profiles on the new Integrity platform, Cortellis Drug Discovery Intelligence. The database name in charts and records has been updated to show the new product name.
  • Reference Rows: Fixed bugs related to the Summarize rule. The software would crash when sorting charts where the column being sorted uses a Summarize rule and there is a group of records for which all cells in a row are blank, or when exporting charts where the first column had a Summarize rule applied.

New and Fixed in Version 5.2.1 (2021-01-11)

  • Support for new structure images in Cortellis exports. NOTE: Prior versions of the Drug Development Suite will crash when importing search results containing these images. If you don't need structure images in your report, earlier versions will still work when you export without images.

Announcing Version 5.2 (2020-08-10)

We are pleased to announce version 5.2 of the BizInt Smart Charts Drug Development Suite.

Drug Pipelines

  • Adds support for the BizInt export from Cortellis Drug Discovery Intelligence, the new generation of Integrity on the Cortellis platform.
  • Introduces two new columns - Indication Phase (Normalized) and Highest Phase (Normalized) - for reports created from drug pipeline databases. Learn more about the new Normalized Phase columns.
  • The Highest Phase (Normalized) column converts the publisher phase to standard BizInt phase terminology (e.g. Phase 1, Phase 1/2, Launched.)
  • The Indication Phase (Normalized) column is a 2-column subtable containing the highest Phase for each Indication, with normalized phase terminology.

Biomedical Literature

  • Updated the list of database segments for for Medline and Embase on Ovid, and fixed publication year processing for all files on Ovid.

Show complete release history